BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34833913)

  • 1. Diterpenes/Diterpenoids and Their Derivatives as Potential Bioactive Leads against Dengue Virus: A Computational and Network Pharmacology Study.
    Khan RA; Hossain R; Siyadatpanah A; Al-Khafaji K; Khalipha ABR; Dey D; Asha UH; Biswas P; Saikat ASM; Chenari HA; Wilairatana P; Islam MT
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An In-Silico Investigation of Phytochemicals as Antiviral Agents Against Dengue Fever.
    Powers CN; Setzer WN
    Comb Chem High Throughput Screen; 2016; 19(7):516-36. PubMed ID: 27151482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus.
    Tahir Ul Qamar M; Maryam A; Muneer I; Xing F; Ashfaq UA; Khan FA; Anwar F; Geesi MH; Khalid RR; Rauf SA; Siddiqi AR
    Sci Rep; 2019 Feb; 9(1):1433. PubMed ID: 30723263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of new potent inhibitors of dengue virus NS5 proteinase from Andrographis paniculata supercritical extracts on in animal cell culture and in silico approaches.
    Kaushik S; Dar L; Kaushik S; Yadav JP
    J Ethnopharmacol; 2021 Mar; 267():113541. PubMed ID: 33152438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
    Dwivedi VD; Tripathi IP; Mishra SK
    J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
    Velmurugan D; Mythily U; Rao K
    Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
    Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
    Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue proteins with their role in pathogenesis, and strategies for developing an effective anti-dengue treatment: A review.
    Nasar S; Rashid N; Iftikhar S
    J Med Virol; 2020 Aug; 92(8):941-955. PubMed ID: 31784997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of Carica papaya bioactive compounds as potential inhibitors of dengue NS2B, NS3 and NS5 protease.
    Farooq MU; Munir B; Naeem S; Yameen M; Iqbal SZ; Ahmad A; Mustaan MA; Noor MW; Nadeem MA; Ghaffar A
    Pak J Pharm Sci; 2020 Jan; 33(1(Supplementary)):355-360. PubMed ID: 32122868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
    Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
    Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach.
    Qamar MT; Ashfaq UA; Tusleem K; Mumtaz A; Tariq Q; Goheer A; Ahmed B
    Pak J Pharm Sci; 2017 Nov; 30(6):2119-2137. PubMed ID: 29175781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Multitarget Antivirals Acting on Both the Dengue Virus NS5-NS3 Interaction and the Host Src/Fyn Kinases.
    Vincetti P; Caporuscio F; Kaptein S; Gioiello A; Mancino V; Suzuki Y; Yamamoto N; Crespan E; Lossani A; Maga G; Rastelli G; Castagnolo D; Neyts J; Leyssen P; Costantino G; Radi M
    J Med Chem; 2015 Jun; 58(12):4964-75. PubMed ID: 26039671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytochemical Compound Screening to Identify Novel Small Molecules against Dengue Virus: A Docking and Dynamics Study.
    Shimu MSS; Mahmud S; Tallei TE; Sami SA; Adam AA; Acharjee UK; Paul GK; Emran TB; Zaman S; Uddin MS; Saleh MA; Alshehri S; Ghoneim MM; Alruwali M; Obaidullah AJ; Jui NR; Kim J; Kim B
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
    Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
    J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory Potential of Chromene Derivatives on Structural and Non-Structural Proteins of Dengue Virus.
    Dharmapalan BT; Biswas R; Sankaran S; Venkidasamy B; Thiruvengadam M; George G; Rebezov M; Zengin G; Gallo M; Montesano D; Naviglio D; Shariati MA
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal 50 amino acid residues of dengue NS3 protein are important for NS3-NS5 interaction and viral replication.
    Tay MY; Saw WG; Zhao Y; Chan KW; Singh D; Chong Y; Forwood JK; Ooi EE; Grüber G; Lescar J; Luo D; Vasudevan SG
    J Biol Chem; 2015 Jan; 290(4):2379-94. PubMed ID: 25488659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
    Lai H; Teramoto T; Padmanabhan R
    Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
    Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
    J Virol; 2017 May; 91(10):. PubMed ID: 28298600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease.
    Bharadwaj S; Lee KE; Dwivedi VD; Yadava U; Panwar A; Lucas SJ; Pandey A; Kang SG
    Sci Rep; 2019 Dec; 9(1):19059. PubMed ID: 31836806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacophoric characteristics of dengue virus NS2B/NS3pro inhibitors: a systematic review of the most promising compounds.
    Leonel CA; Lima WG; Dos Santos M; Ferraz AC; Taranto AG; de Magalhães JC; Dos Santos LL; Ferreira JMS
    Arch Virol; 2018 Mar; 163(3):575-586. PubMed ID: 29147793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.